<p class="section__intro">At its meeting in April 2016, recognising the need for urgent and coordinated action to advance the GET2020 goals, members of the WHO Alliance for Global Elimination of Trachoma by 2020 adopted these commitments by acclamation.</p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <th scope="col">Stakeholder</th>
    <th scope="col">Commitments</th>
  </tr>
  <tr>
    <td>All parties</td>
    <td><strong>Because we achieve more together, to collaborate for GET2020</strong>
    <ul>
<li>Promote trachoma elimination within the context of universal health coverage and as a tracer for poverty alleviation within the Sustainable Development Goals.</li>
<li>Enhance national ownership and partnership for elimination efforts.</li>
<li>Use the latest data to inform elimination plans, promotional materials and funding proposals; and update all relevant information sources.</li>
<li>Use technology where possible to improve efficiency of elimination efforts and reproducibility of data.</li>
<li>Share emerging data and experience to inform current practice and realign priorities as needed for elimination.</li>
<li>Support validation dossier development where requested.</li>
</ul></td>
  </tr>
  <tr>
    <td>World Health Organization</td>
    <td><strong>Provide technical support for trachoma elimination</strong>
<ul>
<li>Revise the template dossier in light of the Morocco experience, and finalize standard operating procedures for dossier review and validation of elimination.</li>
<li>Support dossier development with countries claiming to have eliminated trachoma.</li>
<li>Validate countries as having achieved the elimination of trachoma as a public health problem.</li>
<li>Lead the NTD financing dialogue and publish the economic case for trachoma elimination.</li>
<li>Engage WHO country offices to influence relevant ministries of trachoma-endemic Member States.</li>
<li>Facilitate meetings of the WHO Alliance for GET2020.</li>
<li>Help to maintain the Alliance for GET2020 Database.</li>
<li>Update relevant WHO guidance on trachoma as needed and contribute to the development of implementation tools.</li>
<li>Formalize the Network of WHO Collaborating Centres for Trachoma and contribute to operational research as appropriate.</li>
<li>Lead the standardization of impact surveys and surveillance surveys through the Tropical Data platform.</li>
<li>Contribute to ongoing capacity building efforts.</li></ul></td>
  </tr>
  <tr>
    <td>Governments of endemic countries</td>
    <td><strong>Create a sustainable and enabling environment to eliminate trachoma as a public health problem</strong>
<ul><li>Ensure political commitment to elimination extends from national decision-makers to communities in need.</li>
<li>Increase domestic funding for these initiatives, as an investment in a strong and functioning public health system.</li>
<li>Bring together key decision makers from health, education, WASH and finance ministries; and with donors and implementing partners to better integrate elimination efforts.</li>
<li>Apply the WHO global strategy, “Water, sanitation and hygiene for accelerating and sustaining progress on neglected tropical diseases” to maximise the integration of trachoma and WASH interventions.</li>
<li>Embed targeted hygiene practices relevant to trachoma elimination in school health curricula and health worker training packages.</li>
<li>Work with neighbouring countries to address common trachoma challenges, particularly along shared borders.</li></ul>
</td>
  </tr>
  <tr>
    <td>Public and private donors</td>
    <td><strong>Invest in and recruit additional supporters for trachoma elimination</strong>
<ul><li>Reaffirm our commitments across implementation, research and drug donation.</li>
<li>Create a Donor Coordination Group that meets virtually every quarter to: Review timelines and activities, discuss long-term priorities, and identify opportunities for greater coordination in advocacy and funding, informed by input from other constituencies within the Alliance.</li>
<li>Support the Alliance in developing new partnerships and initiatives to further the goals of GET2020.</li>
<li>Explore the development of a coordinated, proactive advocacy strategy to help raise visibility of the Alliance, and attract new donors and partners.</li>
<li>Recognizing the importance of domestic financing, stand ready to support country efforts.</li></ul>

</td>
  </tr>
  <tr>
    <td>NGOs and other implementing partners</td>
    <td><strong>Support endemic country governments to eliminate trachoma</strong>
<ul><li>Maintain and update Global SAFE Implementation Cost Estimates.</li>
<li>Prioritize strategic resource mobilization and SAFE implementation for all areas with a TF prevalence in 1-9 year-olds ≥30% that are still not under intervention.</li>
<li>Support implementation of high quality TT surgery, through the application of technology to track cases and adoption of protocols for surgical supervision.</li>
<li>Work together to focus efforts on underperforming ‘AFE’ areas, including through raising awareness of the tools available to support decision making, strengthening MDA planning for improved coverage, and coordinating expansion by maximising drug availability and involving WASH partners.</li>
<li>Stand ready to support countries to prepare and submit their dossiers to WHO for validation of elimination.</li></ul>
</td>
  </tr>
  <tr>
    <td>Academic and research institutions</td>
    <td><strong>Prioritise knowledge gaps to address the barriers to eliminating trachoma</strong>
<ul><li>Facilitate the annual Trachoma Scientific Informal Workshop.</li>
<li>Develop and maintain a forum for discussing strategic directions for trachoma research. </li>
<li>Work with ministries of health in endemic countries and other stakeholders to undertake, publish, package and disseminate research that will help accelerate achievement of and validate the global elimination of trachoma; a particular focus should be to include research components in large-scale elimination programmes, as part of multi-centre investigations that address critical questions about the effectiveness of various interventions.</li>
<li>Build scientific capacity in endemic countries in which research is undertaken.</li></ul>
</td>
  </tr>
</table>
